ICD Code D61.810

ICD code D61.810 is antineoplastic chemotherapy-induced pancytopenia, which means a reduction in all types of blood cells caused by cancer treatment drugs.

1. Patient is currently or recently undergoing antineoplastic chemotherapy.

2. Laboratory findings indicate a reduction in all three major blood cell lines: red blood cells (anemia), white blood cells (leukopenia), and platelets (thrombocytopenia).

3. No evidence of alternative causes for pancytopenia, such as bone marrow failure syndromes, infections, or autoimmune disorders.

4. Clinical symptoms may include fatigue, pallor, increased susceptibility to infections, and/or abnormal bleeding or bruising.

5. Temporal relationship established between initiation of chemotherapy and onset of pancytopenia.

Relevant CPT codes that may be used to treat ICD code D61.810 include:

- 96413: Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug

- 96415: Chemotherapy administration, intravenous infusion technique; each additional hour

- 96365: Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour

- 96366: Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour

- 96372: Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular

- 36415: Collection of venous blood by venipuncture

- 38220: Diagnostic bone marrow aspiration

- 38221: Diagnostic bone marrow biopsy

- 85025: Complete blood count (CBC) with automated differential WBC count

- 36410: Venipuncture, age 3 years or older, necessitating physician's skill

These CPT codes are commonly associated with the management and treatment of D61.810.

Schedule a demo to see how MD Clarity’s RevFind software can automatically read your contracts and detect underpayments for CPT codes associated with ICD code D61.810. Ensure your organization is accurately reimbursed—discover how RevFind can help you identify missed revenue opportunities today.